Bioinformatics Services Market: Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new report on the bioinformatics services market. This study includes the statistical and analytical approaches needed to grow the bioinformatics services market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-109688

The global bioinformatics services market is estimated to grow from US $ 1.70 billion in 2018 to US $ 3.53 billion by 2023, with a CAGR of 15.7%.

Factors such as an increase in bioinformatics applications in various industries and a shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects are driving the growth of this market. Increasing public-private sector funding for bioinformatics services is also expected to contribute to the growth of this market.

Report sample URL
https://www.sdki.jp/sample-request-109688

Market segment

The bioinformatics service market is by type (microflora, transcriptome, virtual screening, database management), specialty (medical, forensic), application (proteomics, metabolomics), end user (academic, pharmaceutical). And divided by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

The medical biotechnology segment dominated the market in 2018.

Based on their discipline, the bioinformatics services market is divided into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, and forensic biotechnology. The medical biotechnology segment had the largest share of the bioinformatics services market in 2018. The largest share of this segment could be due to increased funding for the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and the development of bioinformatics solutions for clinical diagnostics. there is.

Academic institutions and research centers are expected to grow at the largest CAGR between 2018-2023.

Based on the end user, the bioinformatics services market is divided into academic institutions and research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. The Academic Institutions and Research Centers segment witnessed the highest growth between 2018-2023. Increasing the scale of genomics research and increasing collaboration between academic research institutes and players in the bioinformatics market are key drivers of growth in this segment. Increasing numbers of government-funded programs for genomics research and increasing market player attention to providing efficient bioinformatics services that meet the requirements of researchers are expected to drive growth in this segment. increase.

Area overview

The Asia Pacific bioinformatics services market is expected to grow at a significant CAGR between 2018-2023. Factors such as an increased incidence of targeted diseases (such as cancer and hereditary diseases) and increased awareness of the clinical applications of bioinformatics and their benefits over traditional methods are driving growth in the region. In addition, growing genomics and drug discovery research activities are driving the growth of the region's bioinformatics services market.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific); Latin America (Brazil, Mexico, Argentina, and other Latin). USA); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy, Spain) , Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Detailed contents of the survey report
https://www.sdki.jp/reports/bioinformatics-services-market/109688

Major key players on the market

Key players in the bioinformatics services market include Illumina (USA), Thermo Fisher Scientific (USA), Eurofins Scientific (Luxembourg), BGI (China), NeoGenomics (USA), PerkinElmer (USA), and CD Genomics (USA). ), Macrogen (Korea), QIAGEN (Germany), GENEWIZ (USA), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), BaseClear (Netherlands) and more. The survey includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these key companies in the bioinformatics services market.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.